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This work proposes a new strategy for the revalorization of residual materials 10 
from table-olive and olive oil production based on the extraction of bioactive peptides. 11 
Enzymatic hydrolysates of the olive seed protein isolate were prepared by treatment with 12 
five different proteases: Alcalase, Thermolysin, Neutrase, Flavourzyme, and PTN. 13 
Although all hydrolysates presented antioxidant properties, Alcalase was the enzyme that 14 
yielded the hydrolysate with the highest antioxidant capacity. All hydrolysates showed 15 
antihypertensive capacity, obtaining IC50 values from 29 to 350 µg/mL. Thermolysin was 16 
the enzyme yielding the hydrolysate with the highest ACE-inhibitory capacity. 17 
Hydrolysates were fractionated by ultrafiltration showing a high concentration of short 18 
chain peptides which exhibited significantly higher antioxidant and antihypertensive 19 
capacities than fractions with higher molecular weights. Peptides in most active fractions 20 
were identified by LC-MS/MS, observing homologies with other recognized antioxidant 21 
and antihypertensive peptides. Finally, their antioxidant and antihypertensive capacities 22 
were evaluated after in vitro gastrointestinal digestion.   23 
 24 
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1. Introduction 31 
The Mediterranean basin provides 97% of the total olive production in the world, 32 
constituting one of the major agro-industrial activities for countries as Spain, Italy, 33 
Greece, Turkey, and Tunisia. Despite the evolutionary changes carried out in olive oil and 34 
table-olive brine production processes, a large volume of residues is still generated in the 35 
processing of this fruit. Olive oil extraction results in two different kinds of waste 36 
materials: the solid waste, also known as olive pomace or olive oil cake, that is a 37 
combination of olive pulp and stone; and an aqueous liquor, the so-called olive mill 38 
wastewater, constituted by vegetation water, soft olive tissues, and water added during 39 
refinement. These residues result in notoriously polluting products that are phytotoxic, 40 
not easily biodegradable, and difficult to treat (Fiorentino et al., 2003; Vlyssides, 41 
Loizides, & Karlis, 2004; Khoufi, Aloui, & Sayadi, 2009). Additionally, the management 42 
of these residues is detrimental for the economic profit of producers. In order to 43 
contribute to environmental sustainability and to maximize economic return, it is 44 
necessary to recover these residues and to look for new opportunities of application. In 45 
this sense, these residues could be useful for the production of substances with high added 46 
value. Examples of similar initiatives have been the recovery of terpenes (Parra,  López, 47 
& García-Granados, 2010), polyphenols (Luján, Capote, Marinas, & Luque de Castro, 48 
2008), and polar lipids (Karantonis et al., 2008) from the oil solid waste while olive mill 49 
and table-olive brine wastewaters have been used for the extraction of phenolic 50 
compounds (Obied et al., 2005; Bouaziz et al., 2008; Hamza, Khoufi, & Sayadi, 2012) 51 
and polar lipids (Karantonis et al., 2008).  52 
Regarding the olive stone, it has been proposed as a cheap source of protein (up to 53 
22%) (Rodríguez et al., 2008). Despite this, it has been mainly used as an energy source 54 





proteins (Rodríguez et al., 2008). Nevertheless, olive seed proteins could be of interest for 56 
the production of valuable substances such as bioactive peptides. Bioactive peptides can 57 
be defined as food components that have a positive impact on body functions or 58 
conditions and may ultimately influence health (Heisel & Fitzgerald, 2003). Bioactive 59 
peptides can demonstrate a wide variety of bioactivities being antihypertensive and 60 
antioxidant peptides the most popular.  61 
Antioxidants intake has been inversely related with aging, cellular death, diabetes, 62 
and cancer. In fact, reactive oxygen species (ROS) cause lipid oxidation, protein 63 
oxidation, DNA strand break and base modification, and modulation of gene expression 64 
(Lee, Koo, & Min, 2004). Moreover, antioxidant compounds are very useful for the 65 
control of lipid oxidation in food products. Peroxidation of fatty acids can cause 66 
deleterious effects in foods resulting in the development of undesirable off-flavors, odors, 67 
dark colors, and potentially toxic reaction products (Rajapaks, Mendis, Jung, Je, & Kim, 68 
2005). The demand for natural antioxidants has increased in the last years because of their 69 
safety and due to the negative consumer perception on synthetic antioxidants (Sakanaka, 70 
Tachibana, Ishihana, & Juneja, 2004; Sakanaka, Tachibana, Ishihara, & Juneja, 2005). On 71 
the other hand, hypertension is an important public-health challenge worldwide (Kearney 72 
et al., 2004). Despite the fact that there are a wide number of synthetic compounds for the 73 
treatment of hypertension, they can produce undesirable effects such as cough, taste 74 
disturbances or rashes. Because of this reason, antihypertensive peptides coming from 75 
food have become an interesting alternative.  76 
Different studies have demonstrated the health benefits of some peptides obtained 77 
from oilseeds protein hydrolysates (García, Puchalska, Esteve, & Marina, 2013). Indeed, 78 





observed in sunflower seeds, rapeseed, maize, peanut, sesame, quinoa, amaranth, and 80 
soybean (Aluko, & Monu, 2003; Megias et al., 2004; Pedroche et al., 2004; Yust et al., 81 
2004; Silva-Sánchez et al., 2008; Ren, Zheng, Liu, & Liu, 2010; Fritz, Vecchi, Rinaldi, & 82 
Añón, 2011). 83 
The objective of the present study is to propose a new strategy for the recovery of 84 
waste proteins from olive seed and to evaluate their potential to produce antioxidant and 85 
antihypertensive peptides. 86 
 87 
2. Materials and methods 88 
2.1. Chemical and samples 89 
 Tris(hydroxymethyl)aminomethane (Tris), hydrochloric acid, sodium dodecyl 90 
sulfate (SDS) (all from Merck, Darmstadt, Germany), ammonium bicarbonate (ABC), 91 
potassium phosphate (PB), dithiothreitol (DTT) (all from Sigma-Aldrich, St. Louis, MO), 92 
and reagent grade acetone (from Scharlau) were used for the extraction and precipitation 93 
of olive seed proteins. Alcalase 2.4 L FG, Neutrase 0.8 L, Flavourzyme 1000 L, and PTN 94 
6.0 Saltfree*N enzymes were kindly donated by Novozymes Spain S. A. (Madrid, Spain). 95 
Thermolysin, porcine pepsin, and pancreatin were obtained from Sigma-Aldrich. Sodium 96 
tetraborate, o-phthaldialdehyde (OPA), 2-mercaptoethanol, 1,1-diphenyl-2-picrylhydrazyl 97 
(DPPH), ethanol (EtOH), glutathione (GSH), 2,2'-azino-bis(3-ethylbenzothiazoline-6-98 
sulphonic acid) (ABTS), potassium persulfate, 6-hydroxy-2,5,7,8-tetramethylchroman-2-99 
carboxylic acid (Trolox), 1,10-phenantroline, linoleic acid, iron (II) chloride, ferrous 100 
sulphate (FeSO4), ammonium thiocyanate, and hydrogen peroxide (H2O2), all obtained 101 





(HHL), hippuric acid (HA), angiotensin converting enzyme (ACE) from rabbit lung, 103 
HEPES, and sodium chloride (Sigma-Aldrich) were used for the ACE-inhibitory assay. 104 
Supergradient HPLC grade acetonitrile (ACN) (Scharlau, Barcelona, Spain), formic acid 105 
(FA), acetic acid (AA) (Sigma-Aldrich), and HPLC grade water (Milli-Q system; 106 
Millipore, Bedford, MA) were used in the preparation of mobile phases. Glycerol and off-107 
gel ampholyte buffer 3-10 from Agilent Tecnologies (Pittsburgh, PA) were used for the 108 
off-gel IEF separation. Raw olives of ‘Arbequina’ variety with violet maturity index were 109 
collected in Toledo (Spain). Olive fruits were manually depulped and stones stored at -20 110 
ºC until use. 111 
2.2. Protein isolation 112 
 Olive stones were crashed to release the seed and seeds were ground in a domestic 113 
mill. Protein extraction from olive seeds was performed by a method previously 114 
developed (Esteve, del Río, Marina, & García, 2010). Briefly, 0.03 g of olive seeds were 115 
mixed with 5 mL of an extracting solution containing 125 mM Tris-HCl (pH 7.5), 1% 116 
(m/v) SDS, and 0.1% (m/v) DTT. The mixture was vigorously shaken for 1 min and 117 
centrifuged twice at 4000g for 10 min. Proteins in the supernatant were precipitated with 118 
25 mL of cold acetone at -20 ºC for 1 h and collected by centrifugation for 10 min at 4 ºC. 119 
Proteins were precipitated again with 10 mL of cold acetone, centrifuged, and dried at 120 
room temperature.  121 
2.3. Hydrolysis of the olive seed protein isolate and ultrafiltration 122 
 The olive seed protein isolate was hydrolysed with five different enzymes 123 
(Alcalase, Thermolysin, Neutrase, PTN, and Flavourzyme) using optimal hydrolysis 124 





to a final concentration of 5 mg/mL. Afterwards, the enzyme was added and the digestion 126 
was carried out for 2 h. Then, the mixture was heated to 100 ºC for 10 min to deactivate 127 
the enzyme and centrifuged at 7000g for 5 min. Enzyme autolysis blanks were obtained 128 
for every enzyme under the same digestion conditions but in absence of sample. The 129 
supernatants were taken for subsequent determination of the degree of hydrolysis (% DH) 130 
and antioxidant and antihypertensive capacities.  131 
 Hydrolysates fractionation by ultrafiltration was performed using Vivaspin 500 132 
PES molecular weight (Mw) cut-off filters (5 kDa) (Sartorius Stedim Biotech, 133 
Goettingen, Germany) and AmiconMw cut-off filters (3 kDa) (Millipore).  134 
 In vitro gastrointestinal digestion was carried out using the method proposed by 135 
Garret et al. (Garret, Failla, & Sarama, 1999). Briefly, most active fractions were 136 
acidified (pH 2.0) with 1 M HCl and mixed with porcine pepsin at an enzyme-to-substrate 137 
ratio of 1:35. The solution was incubated at 37 ºC by shaking at 300 rpm for 1 h. Next, 138 
the pH of the resulting solution was raised to 5.0 by adding 0.1 M sodium bicarbonate and 139 
to 8.0 with 0.1 M sodium hydroxide. Next, pancreatin enzyme dissolved in 0.1 M PB (pH 140 
8.0) was added at an enzyme-to-substrate ratio of 1:25 and samples were incubated by 141 
shaking at 37 ºC for 2 h. Finally, the mixture was heated to 100 ºC for 10 min for the 142 
inactivation of enzyme.  143 
2.4. Peptide separation by off-gel IEF 144 
 Fractionation of hydrolysates by their isoelectric point (pI) was performed using a 145 
3100 OFFGEL Kit pH 3-10 (Agilent Technologies) with a 24-well setup. Prior to sample 146 
loading, IPG gel strips (General Electric, supplied by VWR, Barcelona, Spain), with a 147 





focusing buffer (12% (v/v) glycerol and ampholytes) in every well. Sample (0.72 mL) 149 
was mixed with focusing buffer (2.88 mL) and 150 µL of this mixture were loaded to 150 
every well. The sample was, then, focused at a maximum current of 50 µA and voltages 151 
ranging from 500 to 4000 V until 50 kV/h were reached. Peptides fractionated by their pI 152 
were recovered and subjected to analysis.  153 
2.5. Determination of the degree of hydrolysis (DH, %) 154 
The % DH was determined using OPA (o-phthalaldehyde) method with some 155 
modifications (Want et al., 2008). OPA mixture (5 mL) was obtained by mixing 2.5 mL 156 
of 100 mM sodium tetraborate, 1 mL of 5% (m/v) SDS, 100 µL of 40 mg/mL of OPA 157 
dissolved in MeOH, 10 µL of 2-mercaptoethanol, and 1.39 mL of water. The OPA 158 
mixture (100 µL) was incubated with the sample (2.5 µL) for 8 min at room temperature. 159 
The absorbance at 340 nm of the resulting solution was then measured using a Lambda 35 160 
spectrometer (Perkin-Elmer, Walthman, MA). Peptide concentration was calculated by 161 
interpolation in a calibration curve obtained using GSH (0-5 mg/mL) as standard.  162 
2.6. Measurement of antioxidant capacity 163 
Antioxidant capacity was evaluated by measuring the capability to scavenge 164 
different radicals (DPPH, ABTS, and hydroxyl radicals) and by evaluating the capacity to 165 
inhibit the peroxidation of linoleic acid. Appropriate solvent blanks were run in every 166 
assay. Three individual replicates were measured by triplicate in every determination. 167 
2.6.1. DPPH radical-scavenging assay 168 
Scavenging capacity of olive seed protein hydrolysates against DPPH radicals was 169 
evaluated according to You et al. (You, Zhao, Regenstein, & Ren, 2011) with some 170 





in 95% EtOH. The mixture was kept at room temperature for 30 min and the absorbance 172 
of DPPH radicals was measured at 517 nm. GSH (0-5 mg/mL) was used as positive 173 
control. Scavenging capacity was calculated using the following equation: 174 
















were Abssample is the absorbance corresponding to the sample mixed with DPPH solution; 176 
Abssample control is the absorbance corresponding to the sample mixed with 95% EtOH; and 177 
Absblank is the absorbance obtained with a solution containing digestion buffer mixed with 178 
DPPH solution.  179 
2.6.2. ABTS radical-scavenging assay 180 
ABTS radical scavenging capacity assay was performed according to Wiriyaphan 181 
et al. (Wiriyaphan, Chitsomboon, & Yongsawadigul, 2012) with some modifications. An 182 
ABTS0+ stock solution was prepared by mixing 7.4 mM ABTS solution and 2.6 mM 183 
potassium persulfate solution in 10 mM phosphate buffer (PB) (pH 7.4) and kept in the 184 
dark for 16 h. Fresh ABTS0+ working solution was prepared by diluting ABTS0+ stock 185 
solution in 10 mM PB (pH 7.4) to attain an absorbance of 0.7 ± 0.01 at 734 nm. 1 µL of 186 
hydrolysate was mixed with 100 µL of fresh ABTS0+ working solution. The reaction 187 
mixture was kept in the dark for 6 min and absorbance corresponding to the ABTS0+ 188 
radicals was measured at 734 nm. ABTS radical scavenging capacity was calculated 189 
according to the following equation: 190 

















were Abssample is the absorbance of 1 µL of sample with 100 µL of ABTS
0+ working 192 
solution; and Absblank is the absorbance of 1 µL of buffer with 100 µL of ABTS
0+ working 193 
solution. Furthermore, Trolox equivalent antioxidant capacity (TEAC, concentration of 194 
sample giving the same % of inhibition as 1 mM Trolox) was also determined. For that 195 
purpose, ABTS radical scavenging capacities of hydrolysates and Trolox at five different 196 
concentrations (3-35 µg/mL and 0-15 µM, respectively) were determined and plotted 197 
against their corresponding concentrations. TEAC values were obtained by the 198 
comparison of the slopes corresponding to these plots.  199 
2.6.3. Hydroxyl radical scavenging assay 200 
Hydroxyl radical scavenging capacity was assayed according to the method of 201 
Ajibola et al. (Ajibola, Fashakin, Fagbemi, & Aluko, 2011) with some modifications. 3 202 
mM 1,10-phenanthroline was dissolved in 0.1 M PB (pH 7.4) while FeSO4 (3 mM) and 203 
0.01% (v/v) H2O2 were separately dissolved in distilled water. 25 µL of 1, 10-204 
phenanthroline and 25 µL of FeSO4 were added to 25 µL of sample. To initiate reaction 205 
in wells, 25 µL of H2O2 solution was added to the mixture and incubated at 37 ºC for 1 h. 206 
Thereafter, the absorbance of the mixtures was measured at 536 nm. GSH at 0-5 mg/mL 207 
was used as positive control. Hydroxyl radical scavenging capacity was calculated by 208 
using the following equation: 209 















where Abssample is the absorbance of the sample; Absblank is the absorbance of the blank 211 
solution using distilled water instead of sample; and Abscontrol is the absorbance of a 212 





2.6.4. Lipid peroxidation inhibition assay 214 
The antioxidant capacity of olive seed protein hydrolysates was also evaluated 215 
following a linoleic acid as model according to the method of Chen et al. (Chen, 216 
Muramoto, Yamauchi, & Nokihara, 1996) with some modifications. 20 µL of sample was 217 
mixed with 20 µL of a solution of 0.13% (v/v) of linoleic acid in EtOH and 10 µL of 218 
water. The mixture was incubated for 144 h (6 days) at 40 ºC in the dark and the degree 219 
of oxidation was evaluated at different times by measuring the ferric thyocianate 220 
absorbance (Chen, Muramoto, & Yamauchi, 1995). For that purpose, 2.5 µL of reaction 221 
solution were mixed with 175 µL of 75% (v/v) EtOH, 2.5 µL of 30% (m/v) ammonium 222 
thyocianate, and 2.5 µL of 20 mM ferrous chloride in 3.5% (v/v) HCl. After standing for 223 
3 min, the thyocianate absorbance was measured at 500 nm. Blank digestion was carried 224 
out in absence of sample for every enzyme. GSH at 1 mg/mL was used as positive 225 
control. Lipid peroxidation inhibition capacity was calculated by using the following 226 
equation: 227 






















where Abssample,144h and Abssample,0h are the absorbances for the sample at 144 h and 0 h, 229 
respectively; and Absblank,144h and Absblank,0h are the absorbances for the blank at 144 h and 230 
0 h, respectively. 231 
2.7. Measurement of antihypertensive capacity 232 
ACE (0.05 U/mL) was dissolved in water and HHL (1.25 mg/mL) was dissolved 233 
in 50 mM HEPES buffer (pH 8.3) containing 300 mM NaCl. The resulting solution was 234 





solution. A control reaction mixture containing 5 µL of every digestion buffer was also 236 
employed. After incubation at 37 ºC in a water bath, the reaction was stopped by the 237 
addition of 100 µL ACN at -20 ºC. Finally, HHL and reaction product HA were measured 238 
by HPLC-MS. 239 
HPLC-MS experiments were performed in a modular capillary chromatographic 240 
system (Agilent Technologies) consisting of a micro vacuum degasser (model 1100), a 241 
capillary LC pump (model 1100), a thermostated autosampler (model 1100), a 242 
thermostated column compartment (model 1200), and a multiple wavelength detector 243 
(model 1200). A C18 HPLC column Zorbax 300 SB (150 mm x 0.5 mm ID, 5 µm particle 244 
size, and 80 Å pore size) from Agilent Technologies was employed. The chromatographic 245 
conditions were: flow-rate, 20 µL/min; gradient, 5-100% B in 7 min; mobile phases, 0.5% 246 
(v/v) AA in water (phase A) and 0.5% (v/v) AA in ACN (phase B); injection volume, 1 247 
µL; separation temperature, 25 ºC; and UV detection wavelength, 228 nm.  248 
An ion trap mass spectrometer model amaZon SL (BrukerDaltonics, Bremen, 249 
Germany), equipped with an ESI source was used for quantitation of ACE inhibition as 250 
proposed by Genget al. (Geng, He, Yang, & Wang, 2010). Nebulizer and drying gas 251 
conditions were 6.0 psi and 3.0 L/min at 200 ºC. ESI source operated in the negative ion 252 
mode (+ 3500 V) with an end plate offset of – 500 V. During the analysis, two reference 253 
masses: 121.0509 (C5H4N4) and 922.0098 (C18H18O6N3P3F24) were continuously 254 
measured to allow constant mass correction and obtain accurate masses. [M-H]- ions at 255 
178 m/z (generated from HA) and 428 m/z (generated from HHL) were measured. Data 256 
acquisition and analysis were performed using the DataAnalysis software. ACE inhibition 257 












where c0 is the HA concentration without ACE inhibition and c is the HA concentration 260 
with inhibitor. IC50 values, defined as the concentration of peptide in µg/mL required to 261 
produce 50% inhibition of ACE, were also calculated. For that purpose, different 262 
solutions containing hydrolysate at different final concentrations (0.02-0.3 mg/mL) were 263 
mixed with the reaction mixture and the % of ACE inhibition was calculated. For every 264 
hydrolysate, the % ACE inhibition was plotted against hydrolysate concentration and the 265 
IC50 value was determined from the signal corresponding to a 50% ACE inhibition. 266 
2.8. RP-HPLC separation of hydrolysates 267 
 Separations were carried out in an Agilent Technologies 1100 series liquid 268 
chromatograph (Agilent Technologies) equipped with a diode array detector, an 269 
automatic injector, a degasser system, a quaternary pump, and a thermostated column 270 
compartment. HP Chemstation software was used for instrument control and data 271 
acquisition. Three different reversed-phase HPLC columns were employed: two different 272 
POROS R2/H perfusion columns (50 x 4.6 mm and 100 x 2.1 mm) from Perseptive 273 
Biosystems (Framingham, MA) and one monolithic silica column, Chromolith 274 
Performance RP-18e (100 x 4.6 mm) from Merck. Mobile phases consisted of 0.1% (v/v) 275 
FA in Milli-Q water (mobile phase A) and 0.1% (v/v) FA in ACN (mobile phase B). 276 
Separations were performed using a gradient: 3-30% B in 10 min and 30-95% B in 4 min. 277 
The flow-rate was 1 mL/min, column temperature was 25 ºC, and sample volume was 278 
100 µL. 279 





MS/MS detection was carried out in a Quadrupole Time-of-Flight (Q-TOF) series 281 
6530 mass spectrometer coupled to a liquid chromatograph (model 1100), both from 282 
Agilent Technologies. A guard column Ascentis Express Peptide ES-C18 (5 mm x 2.1 283 
mm, 2.7 µm particle size) and an analytical column Ascentis Express Peptide ES-C18 284 
(100 mm x 2.1 mm, 2.7 µm particle size, 160 Å pore size) were employed for peptide 285 
separation. Mobile phases A and B consisted of 0.1% (v/v) FA in water and 0.1% (v/v) 286 
FA in ACN, respectively. The flow-rate was set to 0.4 mL/min and the gradient was 3% 287 
B during 5 min, 3-20% B in 25 min, and 20-95% B in 5 min. The column temperature 288 
was set at 55 ºC and the injection volume was 20 µL. The mass spectrometer operated 289 
with an ESI Jet Stream source in the positive ion mode and the analyzer in mode MS/MS 290 
scanned in the range 50-3000 m/z. The dry gas conditions were 10 L/min and 300 ºC, the 291 
nebulizer pressure was 50 psig, and the sheath gas flow and temperature were 5.5 L/min 292 
and 250 ºC, respectively. Other MS conditions were: capillary voltage, 3500 V; 293 
fragmentator voltage, 200 V. Collision-induced dissociation (CID) at 35% energy was 294 
used for MS2 experiments. Peaks Studio 6 (Bioinformatics Solutions Inc., Waterloo, ON, 295 
Canada) program was used for the treatment of MS/MS data and do novo peptide 296 
sequencing using an average local confidence (ALC% indicates the expected percentage 297 
of correct amino acids in the peptide sequence) above 90%. Peptide identifications were 298 
accepted if they appeared in, at least, two independent samples. 299 
 300 
3. Results and discussion 301 
Proteins extracted from olive seeds using a previously optimized method (Esteve, 302 
del Río, Marina, & García, 2010) were hydrolysed with five different enzymes: Alcalase, 303 





account bibliographic data on enzymes used to produce bioactive peptides (Aluko, & 305 
Monu, 2003; Klompong, Benjakul, Kantahote, Hayes, & Shahidi, 2008; Wang, Tan, 306 
Chen, & Yan, 2009; Aijoba, Fashakin, Fagbemi, & Aluko, 2011; Valdez-Ortíz, Fuentes-307 
Gutiérrez, Germán-Báez, Gutiérrez-Dorado, & Medina-Godoy, 2012; Wiriyaphan, 308 
Chitsomboon, & Yongsawadigul, 2012). 309 
3.1. Optimization of enzymatic hydrolysis 310 
Table 1 groups the optimal conditions used in the digestion of olive seed proteins 311 
with the selected enzymes. Digestion conditions were chosen after bibliographic revision. 312 
When the % DH obtained using these conditions were not satisfactory, the following 313 
enzymatic parameters were optimized: substrate concentration, reaction time, enzyme 314 
concentration, pH, and digestion buffer. 315 
The substrate concentration was optimized using concentrations ranging from 2.5 316 
to 10.0 mg seed protein isolate/mL and digesting with Alcalase dissolved in PB 5 mM 317 
(pH 8.0) at a temperature of 55 ºC and a digestion time of 2 h. Reaction was monitored by 318 
determining the % DH. The optimum substrate concentration for hydrolysis was 5 mg/mL 319 
since higher concentrations resulted in lower % DH and lower concentrations resulted in 320 
a similar % DH. This protein concentration was employed for all enzymes in order to be 321 
able to compare antioxidant and antihypertensive capacities. Next, the influence of 322 
reaction time, enzyme concentration, pH, and buffer on the % DH was investigated. 323 
Reaction times between 1 and 24 h were assayed with all enzymes. An initial rapid 324 
increase in % DH was observed during the first 2 h followed by a plateau or a very slow 325 
increase in % DH. Consequently, optimum digestion time was established in 2 h for all 326 
enzymes. For some enzymes, different enzyme:substrate ratios were next tried: for 327 





0.01 g enzyme/g protein. The optimum enzyme:substrate ratio, defined as that yielding 329 
maximum % DH, is indicated in Table 1. Higher enzyme concentrations did not result in 330 
an increase in % DH. The influence of pH and buffer on the hydrolysis of the seed protein 331 
isolate was studied for Alcalase, Thermolysin (both with PB (5 mM at pH 8.0) and Tris-332 
HCl buffer (5 mM at pH 8.0 and 9.0)), and Neutrase (PB (5 mM at pH 7.0) and Tris-HCl 333 
buffer (5 mM at pH 7.0)). Results showed the highest % DH when PB was employed, 334 
choosing as optimal conditions PB 5 mM at pH 8.0 for Alcalase and Thermolysin and PB 335 
at pH 7.0 for Neutrase. 336 
Peptide concentrations obtained with every enzyme under optimized conditions 337 
were determined according to the OPA method. Results, summarized in Table 2, showed 338 
that Alcalase was the enzyme yielding the highest hydrolytic activity (% DH of 70.4). 339 
This fact had already been observed with this enzyme (Valdez-Ortíz, Fuentes-Gutiérrez, 340 
Germán-Báez, Gutiérrez-Dorado, & Medina-Godoy, 2012), being the reason why it is one 341 
of the most employed enzymes for the hydrolysis of food proteins. Intermediate 342 
hydrolysis rates were obtained when using Thermolysin, Flavourzyme, and Neutrase, 343 
with 64.6, 61.2, and 59.0% DH, respectively. PTN showed the poorest hydrolysis rate 344 
with 49.6% DH. These results could be explained taking into account that PTN has tryptic 345 
activity and, consequently, a relatively high selectivity while the other enzymes are less 346 
specific.  347 
3.2. Antioxidant capacity of olive seed protein hydrolysates 348 
3.2.1. Radical scavenging capacity  349 
Since the radical system used for the evaluation of antioxidant capacity may 350 





to assess this capacity (Fuglsang, Rattray, Nilsson & Nyborg, 2003). The antioxidant 352 
capacity of protein hydrolysates was determined by the evaluation of their capacity to 353 
scavenge DPPH, ABTS, and hydroxyl radicals, and results are summarized in Table 2.  354 
All obtained hydrolysates were capable of scavenging DPPH radicals. DPPH 355 
radical-scavenging capacities ranged from 42.8 to 68.6 %. The highest antioxidant 356 
capacities were obtained with Alcalase (68.6%) and Neutrase (61.2%) enzymes, while the 357 
lowest capacities were obtained for Flavourzyme (52.5%) and PTN (42.8%).  358 
All protein hydrolysates exhibited good antioxidant capacity when using the 359 
ABTS radical scavenging assay. In fact, antioxidant capacities ranging from 28.9 to 360 
72.0% (TEAC values from 178.6-363.3) were obtained. These TEAC values are in the 361 
range of other protein hydrolysates with recognized antioxidant activity such as that of 362 
Douchi, a traditional Chinese salt-fermented soybean food (Esteve, del Río, Marina, & 363 
García, 2010). Alcalase was again the enzyme showing the highest antioxidant capacity.  364 
All hydrolysates showed capacity to scavenge hydroxyl radicals, being Alcalase 365 
and Neutrase hydrolysates the most active ones. Taking into account the biological 366 
significance of this radical, these results are of great interest from a physiological point of 367 
view. 368 
3.2.2. Lipid peroxidation inhibition capacity 369 
The inhibitory effect of olive seed protein hydrolysates on the peroxidation of 370 
lipids was evaluated using linoleic acid as model. Results obtained are grouped in Table 371 
2. Autooxidation of linoleic acid in absence of antioxidant quickly increased from day 1 372 





peroxidation resulted inhibited. As shown in Table 2, the percentage of linoleic acid 374 
autooxidation inhibition was very high for all hydrolysates, ranging from 79.5 to 91.2%. 375 
Overall, olive seed protein hydrolysates seem to contain antioxidative peptides. 376 
Alcalase hydrolysate, yielding the highest % DH, showed also the highest antioxidant 377 
capacity in all assays. Nevertheless, % DH was not always related with the antioxidant 378 
capacity, as it is observed in the Thermolysin digestion. Therefore, Alcalase hydrolysate 379 
was chosen for its further fractionation.  380 
3.3. Antihypertensive capacity of olive seed protein hydrolysates 381 
The hydrolysates obtained with Alcalase, Thermolysin, Neutrase, Flavourzyme, 382 
and PTN were next screened using the ACE inhibitory assay to evaluate their 383 
antihypertensive capacity. As shown in Table 2, Thermolysin hydrolysate showed the 384 
highest ACE inhibition capacity (29 µg/mL). Thermolysin specially catalyzes the 385 
hydrolysis of peptide bonds containing hydrophobic amino acids and it has been 386 
demonstrated that most powerful antihypertensive peptides contain hydrophobic C-387 
terminal amino acids, as proline, or positive charged ions as lysine or arginine (Fuglsang, 388 
Rattray, Nilsson, & Nyborg). In fact, this enzyme has been widely employed for the 389 
release of hydrophobic peptides from food sources (Puchalska, Marina, & García, 2012). 390 
Alcalase, Neutrase, and PTN showed moderate inhibition capacities, while Flavourzyme 391 
displayed the lowest one. IC50 values were similar to those reported for other seed protein 392 
hydrolysates as quinoa (Megías et al, 2004) and amaranth (Aluko, & Monu, 2003), with 393 
recognized antihypertensive activity.  394 
3.4. Fractionation of hydrolysates and evaluation of antioxidant and antihypertensive 395 





Most antioxidant (Alcalase hydrolysate) and antihypertensive (Thermolysin 397 
hydrolysate) hydrolysates were next fractionated by ultrafiltration. Fractions with 398 
molecular masses > 5 kDa, 3-5 kDa, and < 3 kDa were obtained and peptide 399 
concentration and antioxidant and antihypertensive capacities were evaluated in every 400 
fraction. Figure 1 shows the results obtained for every fraction from the Alcalase 401 
hydrolysate (with the highest antioxidant capacity) in comparison with the whole 402 
Alcalase hydrolysate. The OPA assay showed the highest percentage of peptides in the 403 
fraction with molecular masses below 3 kDa. This fraction also resulted in the greatest 404 
antioxidant capacity being selected for its further fractionation. Similarly, Figure 2 405 
summarizes the peptide concentration and antihypertensive capacity of the fractions 406 
obtained from the Thermolysin hydrolysate. Again, the Thermolysin hydrolysate was 407 
made up mainly of short-chain peptides, with molecular masses below 3 kDa. 408 
Furthermore, IC50 values indicated that the antihypertensive capacity was concentrated on 409 
those small peptides while peptides from 3 to 5 kDa showed the lowest antihypertensive 410 
capacity. These results are in agreement with the knowledge that a lot of ACE inhibitors 411 
are peptides that present short sequences, with a number of amino acids ranging from 2 to 412 
12 (Natesh, Schwager, Sturrok, & Acharya, 2003). 413 
A further attempt to fractionate was next tried with the most antioxidant and 414 
antihypertensive fractions (Alcalase and Thermolysin fractions with peptides below 3 415 
kDa) according to their pI by IEF. Unfortunately, ampholytes employed for the 416 
establishment of the pH gradient highly interfered on the assays used for the evaluation of 417 
the peptide concentration and antioxidant and antihypertensive capacities. In order to 418 
separate ampholytes and peptides, several clean up steps were tried (C18 SPE and RP-419 





As a consequence, further fractionation by IEF was finally rejected and peptides in the 421 
ultrafiltration fractions were next identified. 422 
3.5. Identification of peptides by HPLC-MS/MS 423 
The fractions with molecular masses below 3 kDa, obtained by both the Alcalase 424 
and the Thermolysin hydrolysis, were injected into the HPLC-Q-TOF system for the 425 
identification of peptides. A high percentage of peptides presented a very high 426 
hydrophilic nature, small masses, and +1 charge, which made very difficult their 427 
identification. Figure 3 shows, as examples, the MS/MS spectra obtained for two of the 428 
identified peptides: VLDTGLAGA in the Alcalase hydrolysate and LVVDGEGY in the 429 
Thermolysin hydrolysate.  430 
Table 3 shows the sequences of the identified peptides on each fraction by de 431 
novo sequencing using PEAKS software. Peptide identifications were accepted if they 432 
appeared in, at least, two individual samples, and presented an average local confidence 433 
(ALC%, it indicates the expected percentage of correct amino acids in the peptide 434 
sequence) above 90%. The sequence of every peptide was searched on the BIOPEP 435 
database, but no correspondence with any already reported bioactive peptide was found, 436 
even though this fact does not exclude them as possible potential bioactive peptides.  437 
The antioxidant peptides described in bibliography usually contain between 2 and 438 
15 amino acids and present a high amount of histidine and hydrophobic amino acids 439 
(Erdman, Cheung, & Schroeder, 2008). If we take a look at Table 3.a, we observe a poor 440 
presence of histidine, but a very significant presence of hydrophobic peptides such as 441 
alanine, valine, leucine/isoleucine, proline, methionine, phenylalanine, and tryptophan. It 442 





amino acids as proline or positive charged amino acids as lysine or arginine within the 444 
three amino acids closest to the C-terminal position (Natesh, Schwager, Sturrok, & 445 
Acharya, 2003). Among the identified peptides in the olive seed hydrolysate, the presence 446 
of proline within the last three amino acids was observed in peptides LLPSY, ALMSPH, 447 
and LYSPH. 448 
3.6. Evaluation of antioxidant and antihypertensive capacity of most active fractions after 449 
in vitro gastrointestinal digestion 450 
 Most antioxidant and antihypertensive fractions (fractions < 3 kDa for Alcalase 451 
and Thermolysin hydrolysates) were next subjected to in vitro gastrointestinal digestion 452 
in order to evaluate their resistance to this process. Results obtained revealed a slight 453 
increase in the antioxidant capacity after in vitro gastrointestinal digestion of fraction < 3 454 
kDa from the Alcalase hydrolysate, showing a TEAC value of 382 ± 24. Similarly, the 455 
IC50 value corresponding to the fraction < 3 kDa from the Thermolysin hydrolysate was 456 
slightly higher (36 µg/mL) after gastrointestinal digestion. Regarding % DH, as it was 457 
expected, it increased after the gastrointestinal digestion, being 82.0 ± 5.1 and 69.6 ± 3.6 458 
for Alcalase and Theromolysin hydrolysates, respectively. These data revealed that 459 
antioxidant and antihypertensive peptides extracted from olive seeds seemed to keep their 460 
bioactivities after in vitro gastrointestinal digestion.  461 
 462 
4. Conclusions 463 
Olive seed hydrolysates obtained with five different enzymes demonstrated to 464 
possess antioxidant properties being Alcalase the enzyme yielding the highest capacity. 465 





important antihypertensive capacity. In both cases, the highest capacities were observed 467 
in the fraction containing the smallest peptides (< 3 kDa). HPLC-MS/MS analysis 468 
enabled the identification and do novo sequencing of peptides in these fractions. These 469 
peptides presented common characteristics with other antioxidant and antihypertensive 470 
peptides already described in bibliography. Furthermore, these fractions also maintained 471 
their bioactivities after being subjected to in vitro gastrointestinal digestion. This shows 472 
that olive seed proteins constitute a cheap and valuable source of antioxidant and 473 
antihypertensive peptides. These results could be useful for the proposal of a strategy for 474 
the recovery of this waste material, which in turn could decrease the environmental 475 
impact of these residues and the cost related with their elimination. 476 
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Figure captions 613 
Figure 1. Peptide concentration and ABTS and hydroxyl radical scavenging capacities of 614 
whole Alcalase hydrolysate and fractions with Mw higher than 5 kDa, between 3 and 5 615 
kDa, and lower than 3 kDa. 616 
Figure 2. Peptide concentration and ACE-inhibitory capacity (expressed as IC50) of 617 
whole Thermolysin hydrolysate and fractions with Mw higher than 5 kDa, between 3 and 618 
5 kDa, and lower than 3 kDa.  619 
Figure 3. Fragmentation spectra of VLDTGLAGA (a) and LVVDGEGY (b) peptides 620 
obtained from the fractions with Mw below 3 kDa from the Alcalase and Thermolysin 621 





Table 1. Optimal conditions used for the hydrolysis of the olive seed protein isolate with different enzymes.  




Enzyme:substrate ratio pH (buffer) 
 
Alcalase 50 2  0.15 AU/g protein 8.0 (PB 5 mM)  
Thermolysin 50 2  0.05 g enzyme/g protein 8.0 (PB 5 mM)  
Neutrase 50 2  300 U/g protein 7.0 (PB 5 mM)  
Flavourzyme 50 2  50 U/g protein 6.0 (ABC 5 mM)  






Table 2. Hydrolysis degree (% DH), DPPH, ABTS, and hydroxyl radical scavenging capacities, lipid peroxidation inhibition capacity, and ACE-inhibition 
capacity of olive seed protein hydrolysates.  























Alcalase 70.4 ± 6.2 68.6 ± 5.6 72.0 ± 4.3 363 ± 28 54.5 ± 3.3 91.2 ± 6.9 0.20 ± 0.04 
Thermolysin 64.6 ± 5.7 57.9 ± 4.3 55.2 ± 3.8 178 ± 22 37.3 ± 4.9 83.7 ± 5.9  0.029 ± 0.009 
Neutrase 59.0 ± 4.4 61.2 ± 5.8 46.5 ± 4.9 272 ± 23 54.7 ± 5.0 79.5 ± 8.2 0.21 ± 0.06 
Flavourzym
e 
61.2 ± 6.4 52.5 ± 4.5 50.8 ± 3.1 222 ± 14 43.6 ± 5.2 85.8 ± 5.8 0.35 ± 0.11 
PTN 49.6 ± 4.9 42.8 ± 4.9 28.9 ± 4.6 233 ± 22 31.9 ± 3.6 85.0 ± 6.9 0.22 ± 0.06 
Control  54.3 ± 4.5b 40.4 ± 3.9c  66.1 ± 6.7b 89.1 ± 7.2c  
a Trolox equivalent antioxidant capacity (TEAC) values expressed as micromoles of Trolox equivalents per gram of sample.  










Table 3. Sequence, average local confidence (ALC, %), and mass of peptides identified in the Alcalase fraction showing the highest antioxidant 
capacity (a) and in the Theromolysin fraction with the highest antihypertensive capacity (b). 











Peptide sequence ALC (%) Mass
VLDTGLAGA 96 815.439
VPLSPT 94 612.348
FDGEVK 93 693.333
VLSPPFTGE 93 945.481
MDGAP 92 489.189
APGAGVY 92 633.312
VGPLSPT 91 669.370
VVVVPH 91 648.396
DDLPR 90 614.302
HVAGTVA 90 653.350
MGSPT 90 491.205
VGAPSVS 90 615,323
a) b)
 
 
